Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (787) Ritalin LA (methylphenidate HCl), Novartis,
...Newly Approved Drug Therapies (787) Ritalin LA (methylphenidate HCl), Novartis, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Ritalin LA (methylphenidate HCl) Company: Novartis Approval Status: Approved June 2002 Treatment Area: Attention-Deficit/Hyperactivity Disorder General ...
View Page

2.  Newly Approved Drug Therapies (637) Concerta, Alza,
...stimulant approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Its active ingredient is methylphenidate, and it is available as an extended-release tablet in four tablet strengths (18mg, 27mg, 36mg or 54mg of methylphenidate HCL). Each tablet is designed to have a 12-hour duration of effect. ADHD has ...
View Page

3.  Study Posting (2348) Trial #105861, Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric), New York, NY
...Disorder (ADHD - Pediatric), New York, NY Trial Information Measuring and Predicting Response to Atomoxetine and Methylphenidate Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most frequently occurring disorders of children ...
...Map support@centerwatch.com robyn.palmero@mssm.edu Measuring and Predicting Response to Atomoxetine and Methylphenidate Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) New York, NY 105861 Clinical Trial Participation If you ...
View Page

4.  Study Posting (180) Trial #94223, Smoking Cessation, New York, NY
...York, NY Trial Information Research on ADHD and Smoking A Pilot Study Of Osmotic Release Methylphenidate (OROS-MPH) In Initiating And Maintaining Abstinence In Smokers With Attention Deficit Hyperactivity Disorder. You ...
View Page

5.  Study Posting (180) Trial #94224, Attention Deficit/Hyperactivity Disorder (ADHD - Adults), New York, NY
...York, NY Trial Information Research on ADHD and Smoking A Pilot Study Of Osmotic Release Methylphenidate (OROS-MPH) In Initiating And Maintaining Abstinence In Smokers With Attention Deficit Hyperactivity Disorder. You ...
View Page

6.  Study Posting (2348) Trial #43216, Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric), New York, NY
...to examine and compare the responses of children with different types of ADHD to standard methylphenidate (Ritalin) treatment. Participation involves 5 weeks of treatment: the dose of Ritalin will be gradually ...
...The next 4 weeks consist of one week on each of the 3 doses of methylphenidate and one week on placebo (a pill without any active ingredients, i.e, without any ...
View Page

7.  Newly Approved Drug Therapies (692) Metadate CD, Celltech Pharmaceuticals,
...Area: Attention Deficit Hyperactivity Disorder General Information Metadate CD, a once-daily biphasic formulation of methylphenidate, has been approved for the treatment of attention deficit hyperactivity disorder (ADHD) in patients six ...
...CD capsules, provided by Eurand's novel Diffucaps technology, delivers an initial rapid release of methylphenidate followed by a second continuous release phase. This once-daily regimen effectively controls ADHD symptoms ...
View Page

8.  Newly Approved Drug Therapies (734) Focalin (dexmethylphenidate HCl), Celgene,
...Area: Attention deficit hyperactivity disorder General Information Focalin, a refined formulation of Ritalin (d,l-methylphenidate HCl), has been approved by the FDA for the treatment of attention deficit hyperactivity disorder. Whereas Ritalin contains both the d and l isomers of methylphenidate, Focalin contains only the more active d-isomer. Isomers are compounds that contain the same ...
View Page

9.  Study Posting (2348) Trial #50744, Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric), New York, NY
...the responses of children with different types of Attention Deficit Hyperactivity Disorder (ADHD) to standard methylphenidate (Ritalin) treatment. Participation involves 5 weeks of treatment: the dose of Ritalin will be gradually ...
...study. The next 4 weeks consist of one week on each of 3 doses of methylphenidate and one week on placebo (a pill without any active ingredients, i.e., without Ritalin ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (18), Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
...2002 Celltech reported positive preliminary results from a comparative phase IV clinical trial of Metadate (methylphenidate HCl, USP) and McNeil's Concerta (methylphenidate HCl). Both drugs are indicated for the treatment of attention deficit hyperactivity disorder (ADHD). The ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (499), Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
...reported positive results from a phase IV trial investigating Metadate CD , a biphasic formulation of methylphenidate for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Results showed that 71% of subjects ...
View Page

12.  Newly Approved Drug Therapies (813) Strattera (atomoxetine HCl), Eli Lilly,
...children aged 7 to 13 (Study 3, N=147; Study 4, N=144), Strattera and methylphenidate were compared with placebo. Strattera was administered as a divided dose in the early morning ...
View Page

13.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...Oral tablet for the treatment of depression and panic disorder, Approved February 2002 Ritalin LA (methylphenidate HCl) ; Novartis; Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002 ...
View Page

14.  CenterWatch: Pediatrics/Neonatology Approved Drug Therapies
...2002 Qvar (beclomethasone dipropionate) ; Ivax; For the treatment of asthma, Approved May 2002 Ritalin LA (methylphenidate HCl) ; Novartis; Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002 ...
View Page

15.  CenterWatch: List of Newly Approved Drug Thearapies
...2002 Qvar (beclomethasone dipropionate) ; Ivax; For the treatment of asthma, Approved May 2002 Ritalin LA (methylphenidate HCl) ; Novartis; Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002 ...
...Oral tablet for the treatment of depression and panic disorder, Approved February 2002 Ritalin LA (methylphenidate HCl) ; Novartis; Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD), Approved June 2002 ...
View Page

16.  CenterWatch: Clinical Trials in Category (18) Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
...Substance Abuse New York : Mount Sinai Medical Center Measuring and Predicting Response to Atomoxetine and Methylphenidate New York : Mount Sinai Medical Center Stimulant Drug Treatment of ADHD, Inattentive Type New York ...
View Page

17.  Study Posting (1819) Trial #94143, Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric), Cincinnati, OH
...potential risks in this study are possible side effects from the drugs. Risks associated with methylphenidate include the following: nervousness, insomnia (trouble sleeping), skin rash, appetite loss, nausea, dizziness, abnormal heartbeat ...
View Page